1. Home
  2. ASUR vs TTRX Comparison

ASUR vs TTRX Comparison

Compare ASUR & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Asure Software Inc

ASUR

Asure Software Inc

SELL

Current Price

$7.42

Market Cap

261.9M

Sector

Technology

ML Signal

SELL

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

SELL

Current Price

$11.11

Market Cap

298.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ASUR
TTRX
Founded
1985
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
261.9M
298.8M
IPO Year
1996
2025

Fundamental Metrics

Financial Performance
Metric
ASUR
TTRX
Price
$7.42
$11.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
2
Target Price
$13.11
★ $25.00
AVG Volume (30 Days)
90.2K
★ 145.0K
Earning Date
10-29-2026
11-25-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $88,952,000.00
N/A
Revenue This Year
$14.25
N/A
Revenue Next Year
$8.65
$900.00
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 63.39
N/A
52 Week Low
$6.80
$2.57
52 Week High
$10.20
$16.45

Technical Indicators

Market Signals
Indicator
ASUR
TTRX
Relative Strength Index (RSI) 35.82 42.42
Support Level $7.36 $9.02
Resistance Level $7.98 $14.39
Average True Range (ATR) 0.26 1.25
MACD -0.03 -0.41
Stochastic Oscillator 30.69 1.09

Price Performance

Historical Comparison
ASUR
TTRX

About ASUR Asure Software Inc

Asure Software Inc is a provider of cloud-based Human Capital Management (HCM) software solutions delivered as Software-as-a-Service (SaaS) to businesses of all sizes. It facilitates small and mid-sized businesses (SMBs) to develop their Human Capital to get to the next level, stay compliant, and allocate their time, money, and technology toward growth. The company's HCM suite, named AsureHCM, includes cloud-based Payroll and Tax, HR, a Time and Attendance software. Its HR services range from HR projects to outsourcing payroll to HR consulting services. The firm sells its products majorly in the United States.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: